Felodipine versus Moduretic. A double-blind parallel-group multicentre study

Area of Science:

• Cardiology
• Pharmacology

Background:

• Essential hypertension is a prevalent cardiovascular condition requiring effective management.
• Current antihypertensive therapies vary in efficacy and side effect profiles.

Purpose of the Study:

• To compare the efficacy and safety of felodipine versus Moduretic in treating mild to moderate essential hypertension.
• To evaluate blood pressure reduction and adverse drug experiences (ADEs) associated with each treatment.

Main Methods:

• A double-blind, parallel-group study involving 133 patients with mild to moderate essential hypertension.
• Randomization to felodipine (5mg twice daily, increased to 10mg twice daily) or Moduretic mite (later Moduretic).
• Blood pressure monitoring and assessment of ADEs throughout the study period.

Main Results:

• Both felodipine and Moduretic significantly reduced supine blood pressure.
• No statistically significant difference in blood pressure reduction was observed between the two groups.
• More patients on felodipine were withdrawn due to ADEs, while Moduretic use led to decreased potassium and increased uric acid levels.

Conclusions:

• Felodipine and Moduretic are effective treatments for mild to moderate essential hypertension.
• The choice of therapy may depend on individual patient profiles and tolerance to side effects.
• Further research may explore long-term outcomes and specific patient subgroups.